ZA915905B - Cyclopentane derivatives,process for their production and their pharmaceutical use - Google Patents
Cyclopentane derivatives,process for their production and their pharmaceutical useInfo
- Publication number
- ZA915905B ZA915905B ZA915905A ZA915905A ZA915905B ZA 915905 B ZA915905 B ZA 915905B ZA 915905 A ZA915905 A ZA 915905A ZA 915905 A ZA915905 A ZA 915905A ZA 915905 B ZA915905 B ZA 915905B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical use
- production
- cyclopentane derivatives
- formula
- cyclopentane
- Prior art date
Links
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 title abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4024347A DE4024347A1 (de) | 1990-07-27 | 1990-07-27 | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA915905B true ZA915905B (en) | 1992-04-29 |
Family
ID=6411402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA915905A ZA915905B (en) | 1990-07-27 | 1991-07-26 | Cyclopentane derivatives,process for their production and their pharmaceutical use |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0541594B1 (fr) |
JP (1) | JPH06502390A (fr) |
AT (1) | ATE122036T1 (fr) |
AU (1) | AU8221291A (fr) |
CA (1) | CA2088161A1 (fr) |
DE (3) | DE4024347A1 (fr) |
DK (1) | DK0541594T3 (fr) |
ES (1) | ES2074721T3 (fr) |
IE (1) | IE67507B1 (fr) |
IL (1) | IL98970A0 (fr) |
PT (1) | PT98464B (fr) |
WO (1) | WO1992002495A1 (fr) |
ZA (1) | ZA915905B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4036140A1 (de) * | 1990-11-09 | 1992-05-14 | Schering Ag | 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
AU687906B2 (en) * | 1993-12-15 | 1998-03-05 | Alcon Laboratories, Inc. | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
SK3382000A3 (en) * | 1997-09-09 | 2000-10-09 | Procter & Gamble | A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders |
TR200000671T2 (tr) * | 1997-09-09 | 2000-07-21 | The Procter & Gamble Company | FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler. |
SK3362000A3 (en) * | 1997-09-09 | 2000-10-09 | Procter & Gamble | A compound analogous to prostaglandin f and use thereof |
US6242493B1 (en) | 1998-03-13 | 2001-06-05 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
WO1999047497A2 (fr) * | 1998-03-13 | 1999-09-23 | Merck Frosst Canada & Co. | Acides carboxyliques et acylsulfonamides, compositions contenant ces composes et methodes de traitement |
NZ513825A (en) | 1999-03-05 | 2001-09-28 | Procter & Gamble | C 16 unsaturated FP-selective prostaglandins analogs |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US7323591B2 (en) * | 2006-01-10 | 2008-01-29 | Allergan, Inc. | Substituted cyclopentanes or cyclopentanones as therapeutic agents |
WO2009140205A2 (fr) * | 2008-05-15 | 2009-11-19 | Allergan, Inc. | Cyclopentanes substitués à visée thérapeutique |
CN102336754B (zh) * | 2010-07-15 | 2017-04-12 | 浙江奥翔药业股份有限公司 | 恩替卡韦的合成方法及其中间体化合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1431561A (en) * | 1973-01-31 | 1976-04-07 | Ici Ltd | Cyclopentane derivatives |
IT1053781B (it) * | 1974-09-25 | 1981-10-10 | Erba C S P A Ora Farmitalia | Omega nor cicloalcil 13.14 deidro prostaglandine |
FR2349328A1 (fr) * | 1976-04-30 | 1977-11-25 | Roussel Uclaf | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
DE3126924A1 (de) * | 1981-07-03 | 1983-01-20 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel |
DE3325175A1 (de) * | 1983-07-08 | 1985-01-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3510978A1 (de) * | 1985-03-22 | 1986-09-25 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
ES2054860T5 (es) * | 1987-07-17 | 2003-11-01 | Schering Ag | Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos. |
DE3923797A1 (de) * | 1989-07-14 | 1991-01-24 | Schering Ag | 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
-
1990
- 1990-07-27 DE DE4024347A patent/DE4024347A1/de not_active Withdrawn
-
1991
- 1991-07-22 ES ES91912997T patent/ES2074721T3/es not_active Expired - Lifetime
- 1991-07-22 AU AU82212/91A patent/AU8221291A/en not_active Abandoned
- 1991-07-22 EP EP91912997A patent/EP0541594B1/fr not_active Expired - Lifetime
- 1991-07-22 DE DEDE9100609T patent/DE4191848D2/de not_active Expired - Fee Related
- 1991-07-22 CA CA002088161A patent/CA2088161A1/fr not_active Abandoned
- 1991-07-22 AT AT91912997T patent/ATE122036T1/de not_active IP Right Cessation
- 1991-07-22 DK DK91912997.3T patent/DK0541594T3/da active
- 1991-07-22 WO PCT/DE1991/000604 patent/WO1992002495A1/fr active IP Right Grant
- 1991-07-22 JP JP3512332A patent/JPH06502390A/ja active Pending
- 1991-07-22 DE DE59105400T patent/DE59105400D1/de not_active Expired - Lifetime
- 1991-07-26 ZA ZA915905A patent/ZA915905B/xx unknown
- 1991-07-26 IL IL98970A patent/IL98970A0/xx unknown
- 1991-07-26 PT PT98464A patent/PT98464B/pt not_active IP Right Cessation
- 1991-07-29 IE IE265491A patent/IE67507B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0541594B1 (fr) | 1995-05-03 |
DE4191848D2 (de) | 1993-10-07 |
IE912654A1 (en) | 1992-01-29 |
IE67507B1 (en) | 1996-04-03 |
IL98970A0 (en) | 1992-07-15 |
CA2088161A1 (fr) | 1992-01-28 |
DE59105400D1 (de) | 1995-06-08 |
ES2074721T3 (es) | 1995-09-16 |
WO1992002495A1 (fr) | 1992-02-20 |
PT98464B (pt) | 1997-10-31 |
DK0541594T3 (da) | 1995-10-02 |
PT98464A (pt) | 1992-05-29 |
AU8221291A (en) | 1992-03-02 |
JPH06502390A (ja) | 1994-03-17 |
ATE122036T1 (de) | 1995-05-15 |
DE4024347A1 (de) | 1992-01-30 |
EP0541594A1 (fr) | 1993-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO941678L (no) | nor-gallesyrederivater, fremgangsmåte for fremstilling og anvendelse av dem som legemiddel | |
ZA915905B (en) | Cyclopentane derivatives,process for their production and their pharmaceutical use | |
MY113274A (en) | Omeprazole magnesium salt form | |
DK0859766T3 (da) | Chirale methylphenyloxazolidinoner | |
ES2072163T3 (es) | Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina. | |
MX9803672A (es) | Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos. | |
CY1112050T1 (el) | Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα | |
MX9601635A (es) | Derivados de antraciclina. | |
IL113744A0 (en) | 3-Cephem derivatives and their preparation | |
GR3015149T3 (en) | Urea derivatives, their production, and pharmaceutical compositions containing them. | |
UA35556C2 (uk) | Спосіб одержання гідрокортизону та проміжні сполуки в синтезі гідрокортизону | |
GR3018360T3 (en) | Cyclopentane derivatives, process for producing them and their pharmaceutical use. | |
HUT61461A (en) | Process for producing new pharmaceutical compositions comprising bambuterol | |
ATE298336T1 (de) | Verfahren zur herstellung von thiazolidinedion- derivaten und zwischenprodukte | |
MY106512A (en) | Process for the preparation of 6-(substitutedaminopro- pionyl)-derivatives of fokskolin. | |
GR3019568T3 (en) | Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals | |
ATE40380T1 (de) | Anthracykline verbindung, verfahren zu deren herstellung, deren pharmazeutische zusammensetzung und deren verwendung als arzneimittel. | |
ES8704148A1 (es) | Un procedimiento para preparar derivados de antraciclina | |
DE59105961D1 (de) | 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln. | |
MX9803556A (es) | Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producirlos. | |
JO1652B1 (en) | New compounds for local anesthesia and a way to prepare them |